Literature DB >> 16310048

Extensive T cell receptor cross-reactivity on structurally diverse haptenated peptides presented by HLA-A2.

Susan J Gagnon1, Richard V Turner, Michael G Shiue, Marale Damirjian, William E Biddison.   

Abstract

Previous studies have shown that individual TCRs are able to effectively recognize multiple peptide/MHC complexes that have varying degrees of structural diversity. These TCR cross-reactivities have usually been demonstrated by using peptides that have different amino acid sequences. To further examine the extent to which TCRs can accommodate structurally diverse ligands, we analyzed human TCR cross-reactivity to eight structurally distinct haptens that are coupled to the HLA-A2-binding Tax peptide with a lysine substitution at position 5 (Tax-5K, LLFG[K-hapten]PVYV). The results demonstrate that 71% percent of the haptenated-peptide-induced CTL lines could cross-react on at least one other hapten. We compared the effects of HLA-A2 mutants with substitutions at known TCR contact sites for recognition by hapten-cross-reactive CTL. Recognition of the A2 mutants was remarkably similar whether they were presenting the immunizing or the cross-reactive peptide, indicating that similar amino acid contacts are made by the TCR during recognition of both complexes. Thus, hapten cross-reactivity is apparently accomplished without major adjustments to the interaction between the TCR and the surface of the HLA-A2 molecule. Collectively, these results suggest that TCRs possess the molecular flexibility to accommodate very structurally diverse ligands while retaining conserved interactions with the surface of the MHC molecule.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16310048     DOI: 10.1016/j.molimm.2005.02.011

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

1.  Conformational melding permits a conserved binding geometry in TCR recognition of foreign and self molecular mimics.

Authors:  Oleg Y Borbulevych; Kurt H Piepenbrink; Brian M Baker
Journal:  J Immunol       Date:  2011-01-31       Impact factor: 5.422

2.  Characterization of the Class I MHC Peptidome Resulting From DNCB Exposure of HaCaT Cells.

Authors:  Alistair Bailey; Ben Nicholas; Rachel Darley; Erika Parkinson; Ying Teo; Maja Aleksic; Gavin Maxwell; Tim Elliott; Michael Ardern-Jones; Paul Skipp
Journal:  Toxicol Sci       Date:  2021-02-26       Impact factor: 4.849

3.  Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study.

Authors:  Amit Kumar; Eleonora Cocco; Luigi Atzori; Maria Giovanna Marrosu; Enrico Pieroni
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

4.  Nonstimulatory peptide-MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling.

Authors:  Xiang Zhao; Shvetha Sankaran; Jiawei Yap; Chien Tei Too; Zi Zong Ho; Garry Dolton; Mateusz Legut; Ee Chee Ren; Andrew K Sewell; Antonio Bertoletti; Paul A MacAry; Joanna Brzostek; Nicholas R J Gascoigne
Journal:  Nat Commun       Date:  2018-07-13       Impact factor: 14.919

5.  Long-term human coronavirus-myelin cross-reactive T-cell clones derived from multiple sclerosis patients.

Authors:  Annie Boucher; Marc Desforges; Pierre Duquette; Pierre J Talbot
Journal:  Clin Immunol       Date:  2007-04-19       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.